Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein

Journal of Infectious Diseases

Volumn 190, Issue 6, 2004, Pages 1140-1149

  Fowler Jr , Vance G ^a   Sakoulas, George ^b   McIntyre, Lauren M ^a,c   Meka, Venkata G ^d   Arbeit, Robert D ^e   Cabell, Christopher H ^a   Stryjewski, Martin E ^a   Eliopoulos, George M ^d   Reller, L Barth ^a   Corey, G Ralph ^a   Jones, Tiffanny ^f   Lucindo, Natalie ^f   Yeaman, Michael R ^f,g   Bayer, Arnold S ^f,g  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Crystal Run Healthcare   (United States)

^c PURDUE UNIVERSITY   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e Transcept Pharmaceuticals Inc   (United States)

^f HARBOR UCLA MEDICAL CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; RIFAMPICIN; THROMBIN; VANCOMYCIN;

ABSCESS; AGED; ARTICLE; AUTOLYSIS; BACTEREMIA; BACTERIAL ARTHRITIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOCARDITIS; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIVARIATE ANALYSIS; OSTEOMYELITIS; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; BETA-THROMBOGLOBULIN; CHEMOKINES; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DNA FINGERPRINTING; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GENOTYPE; HEMOLYSIN PROTEINS; HUMANS; MALE; METHICILLIN RESISTANCE; PHENOTYPE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TRANS-ACTIVATORS;

EID: 4444346026     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/423145     Document Type: Article

References (50)

1. Levine DP, Fromm BS, Reddy BR. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med 1991; 115:674-80.
2. Markowitz N, Quinn EL, Saravolatz LD. Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Ann Intern Med 1992; 117:390-8.
3. Eng RH, Bishburg E, Smith SM, Scadutto P. Staphylococcus aureus bacteremia during therapy. J Infect Dis 1987; 155:1331-5.
4. Yeaman MR. The role of platelets in antimicrobial host defense. Clin Infect Dis 1997; 25:951-68.
5. Bayer AS, Cheng D, Yeaman MR, et al. In vitro resistance to thrombin-induced platelet microbicidal protein among clinical bacteremic isolates of Staphylococcus aureus correlates with an endovascular infectious source. Antimicrob Agents Chemother 1998; 42:3169-72.
6. Bayer AS, Prasad R, Chandra J, et al. In vitro resistance of Staphylococcus aureus to thrombin-induced platelet microbicidal protein is associated with alterations in cytoplasmic membrane fluidity. Infect Immun 2000; 68:3548-53.
7. Dankert J, Krijgsveld J, van Der WJ, Joldersma W, Zaat SA. Platelet microbicidal activity is an important defense factor against viridans streptococcal endocarditis. J Infect Dis 2001; 184:597-605.
8. Dhawan VK, Yeaman MR, Cheung AL, Kim E, Sullam PM, Bayer AS. Phenotypic resistance to thrombin-induced platelet microbicidal protein in vitro is correlated with enhanced virulence in experimental endocarditis due to Staphylococcus aureus. Infect Immun 1997; 65: 3293-9.
9. Dhawan VK, Bayer AS, Yeaman MR. In vitro resistance to thrombin-induced platelet microbicidal protein is associated with enhanced progression and hematogenous dissemination in experimental Staphylococcus aureus infective endocarditis. Infect Immun 1998; 66:3476-9.
10. Fowler VG Jr, McIntyre LM, Yeaman MR, et al. In vitro resistance to thrombin-induced platelet microbicidal protein in isolates of Staphylococcus aureus from endocarditis patients correlates with an intravascular device source. J Infect Dis 2000; 182:1251-4.
11. Kupferwasser LI, Yeaman MR, Shapiro SM, Nast CC, Bayer AS. In vitro susceptibility to thrombin-induced platelet microbicidal protein is associated with reduced disease progression and complication rates in experimental Staphylococcus aureus endocarditis: microbiological, histopathologic, and echocardiographic analyses. Circulation 2002; 105: 746-52.
12. Wu T, Yeaman MR, Bayer AS. In vitro resistance to platelet microbicidal protein correlates with endocarditis source among bacteremic staphylococcal and streptococcal isolates. Antimicrob Agents Chemother 1994; 38:729-32.
13. Xiong YQ, Yeaman MR, Bayer AS. In vitro antibacterial activities of platelet microbicidal protein and neutrophil defensin against Staphylococcus aureus are influenced by antibiotics differing in mechanism of action. Antimicrob Agents Chemother 1999; 43:1111-7.
14. Xiong YQ, Bayer AS, Yeaman MR. Inhibition of intracellular macromolecular synthesis in Staphylococcus aureus by thrombin-induced platelet microbicidal proteins. J Infect Dis 2002; 185:348-56.
15. Yeaman MR, Puentes SM, Norman DC, Bayer AS. Partial purification and staphylocidal activity of thrombin-induced platelet microbicidal protein. Infect Immun 1992; 60:1202-9.
16. Fujimoto DF, Bayles KW. Opposing roles of the Staphylococcus aureus virulence regulators, Agr and Sar, in Triton X-100- and penicillin-induced autolysis. J Bacteriol 1998; 180:3724-6.
17. Novick RP. Pathogenicity factors and their regulation. In: Fischett VA, Novick RP, Ferretti JJ, Portnoy DA, Rood JI, eds. Washington, DC: American Society for Microbiology, 2000:392-407.
18. Jarraud S, Mougel C, Thioulouse J, et al. Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect Immun 2002; 70:631-41.
19. Jarraud S, Lyon GJ, Figueiredo AM, et al. Exfoliatin-producing strains define a fourth agr specificity group in Staphylococcus aureus. J Bacteriol 2000; 182:6517-22.
20. Sakoulas G, Eliopoulos GM, Moellering RC Jr, et al. Staphylococcus aureus accessory gene regulator (agr) group II: is there a relationship to the development of intermediate-level glycopeptide resistance? J Infect Dis 2003; 187:929-38.
21. Sakoulas G, Eliopoulos GM, Lucindo N, et al. Loss of accessory gene regulator (agr) function and exposure to vancomycin are associated with Staphylococcus aureus resistance to autolysis and thrombin-induced microbicidal proteins in vitro [abstract C1-1741]. In: Programs and Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). Washington, DC: American Society of Microbiology, 2003:94.
22. Sakoulas G, Eliopoulos GM, Moellering RC Jr, et al. Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin. Antimicrob Agents Chemother 2002; 46:1492-502.
23. Fowler VG Jr, Olsen MK, Corey GR, et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 2003; 163: 2066-72.
24. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13:818-29.
25. Fowler VG Jr, Kong LK, Corey GR, et al. Recurrent Staphylococcus aureus bacteremia: pulsed-field gel electrophoresis findings in 29 patients. J Infect Dis 1999; 179:1157-61.
26. National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for antimicrobial susceptibility testing: twelfth informational supplement [M100-S12]. Wayne, PA: NCCLS, 2002.
27. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-74.
28. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128-40.
29. Libman H, Arbeit RD. Complications associated with Staphylococcus aureus bacteremia. Arch Intern Med 1984; 144:541-5.
30. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994; 96:200-9.
31. Moore PC, Lindsay JA. Genetic variation among hospital isolates of methicillin-sensitive Staphylococcus aureus: evidence for horizontal transfer of virulence genes. J Clin Microbiol 2001; 39:2760-7.
32. Ji G, Beavis R, Novick RP. Bacterial interference caused by autoinducing peptide variants. Science 1997; 276:2027-30.
33. Yeaman MR, Tang YQ, Shen AJ, Bayer AS, Selsted ME. Purification and in vitro activities of rabbit platelet microbicidal proteins. Infect Immun 1997; 65:1023-31.
34. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33:2233-9.
35. Shimizu A, Berkhoff HA, Kloos WE, George CG, Ballard DN. Genomic DNA fingerprinting, using pulsed-field gel electrophoresis, of Staphylococcus intermedius isolated from dogs. Am J Vet Res 1996; 57: 1458-62.
36. Sneath HA, Sokol RR. Numerical taxonomy: the principles and practice of numerical classification. San Francisco: WH Freeman, 1973.
37. Khatib R, Johnson LB, Fakih MG, et al. Predictors of persistence (PER) in Staphylococcus aureus bacteremia (SAB): a prospective study [abstract: K-763]. In: Programs and Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). Washington, DC: American Society of Microbiology, 2003:371.
38. Adhikari RP, Smith JMB, Berger-Bachi B, Cook GM. Decreased oxacillin resistance and RNAIII transcription in Staphylococcus aureus laboratory mutants with decreased susceptibility to vancomycin [abstract C1-1740]. In: Programs and Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). Washington, DC: American Society of Microbiology, 2003:94.
39. Renzoni A, Francois P, Li D, et al. Modulation of fibronectin-binding proteins (FnBP) expression in a teicoplanin resistant mutant of methicillin-resistant Staphylococcus aureus (MRSA) [abstract C1-1062]. In: Programs and Abstracts of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (San Diego). Washington, DC: American Society for Microbiology, 2002:71.
40. Bischoff M and Berger-Bachi B. Teicoplanin stress-selected mutations increasing sigma(B) activity in Staphylococcus aureus. Antimicrob Agents Chemother 2001; 45:1714-20.
41. Moise-Broder PA, Sakoulas G, Eliopoulos GM, Schentag JJ, Forrest AA, Moellering RC Jr. Association of the accessory gene regulator specificity group II and response of methicillin-resistant Staphylococcus aureus infections to vancomycin [abstract C1-1059]. In: Programs and Abstracts of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (San Diego). Washington, DC: American Society for Microbiology, 2002:70.
42. Dhawan VK, Bayer AS, Yeaman MR. Thrombin-induced platelet microbiddal protein susceptibility phenotype influences the outcome of oxacillin prophylaxis and therapy of experimental Staphylococcus aureus endocarditis. Antimicrob Agents Chemother 2000; 44:3206-9.
43. Boyle-Vavra S, Challapalli M, Daum RS. Resistance to autolysis in vancomycin-selected Staphylococcus aureus isolates precedes vancomycin- intermediate resistance. Antimicrob Agents Chemother 2003; 47:2036-9.
44. Brunskill EW, Bayles KW. Identification and molecular characterization of a putative regulatory locus that affects autolysis in Staphylococcus aureus. J Bacteriol 1996; 178:611-8.
45. Bierbaum G, Sahl HG. Induction of autolysis of staphylococci by the basic peptide antibiotics Pep 5 and nisin and their influence on the activity of autolytic enzymes. Arch Microbiol 1985; 141:249-54.
46. Bierbaum G, Sahl HG. Influence of cationic peptides on the activity of the autolytic endo-beta-N-acetylglucosaminidase of Staphylococcus simulans 22. FEMS Microbiol Lett 1989; 49:223-7.
47. Moreillon P, Que YA, Bayer AS. Pathogenesis of streptococcal and staphylococcal endocarditis. Infect Dis Clin North Am 2002; 16: 297-318.
48. Massey RC, Kantzanou MN, Fowler T, et al. Fibronectin-binding protein A of Staphylococcus aureus has multiple, substituting, binding regions that mediate adherence to fibronectin and invasion of endothelial cells. Cell Microbiol 2001; 3:839-51.
49. Sinha B, Francois PP, Nusse O, et al. Fibronectin-binding protein acts as Staphylococcus aureus invasin via fibronectin bridging to integrin alpha5beta1. Cell Microbiol 1999; 1:101-17.
50. Sinha B, Herrmann M, Krause KH. Is Staphylococcus aureus an intracellular pathogen? Trends Microbiol 2000; 8:343-4.